ACTRN12624000720516
Recruiting
未知
A Randomised Controlled Trial Evaluating an In-Person, Clinician-Facilitated and an Online, Guided Self-Help Program for University Students with Social Anxiety
Professor Elizabeth Rieger0 sites90 target enrollmentJune 12, 2024
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Social Anxiety Disorder
- Sponsor
- Professor Elizabeth Rieger
- Enrollment
- 90
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Must be diagnosed with Social Anxiety Disorder by a registered psychologist or provisional psychologist in the Psychology Clinic of the Australian National University.
- •Enrolled as a student at the Australian National University or the University of Canberra.
Exclusion Criteria
- •Current suicidal intent, psychotic illness, substance use disorder or severe depression. Exclusion criteria are assessed during initial screening in individual meetings with a registered psychologist or provisional psychologist in the Psychology Clinic of the Australian National University.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
This is a study to Evaluate the Safety and Efficacy of ABBV-154 in Subjects with Moderately to Severely Active Crohn's Disease (CD)Subjects with moderately to severely active Crohn's diseaseMedDRA version: 20.0Level: PTClassification code 10011401Term: Crohn's diseaseSystem Organ Class: 10017947 - Gastrointestinal disordersTherapeutic area: Diseases [C] - Immune System Diseases [C20]EUCTR2021-002869-18-BEAbbVie Deutschland GmbH & Co. KG265
Active, not recruiting
Phase 1
Clinical Trial to compare if seriously-ill adults with constipation due to narcotics have bowel movements sooner after injection with Methylnatrexone or placeboEUCTR2007-000854-30-BESalix Pharmaceuticals Inc254
Active, not recruiting
Not Applicable
A study to evaluate the effect and safety of a 4 week treatment plan of Alirocumab in patients with high cholesterolPrimary HypercholesterolemiaMedDRA version: 17.0Level: LLTClassification code 10020604Term: HypercholesterolemiaSystem Organ Class: 100000004861Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]EUCTR2013-002343-29-GBRegeneron Pharmaceuticals, Inc.803
Active, not recruiting
Not Applicable
A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Tolerability of E5555, and its Effects on Markers of Intravascular Inflammation in Subjects with Coronary Artery Disease - E5555-G000-201Coronary Artery DiseaseMedDRA version: 8.1Level: PTClassification code 10011078EUCTR2005-006029-94-BEEisai Limited720
Completed
Not Applicable
A Randomized, Double-Blind, Placebo-Controlled Study in Healthy Male Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Ascending Oral Doses of JNJ-26070109abdominal pain and heartburn10017943NL-OMON30044Janssen-Cilag82